T. Sato et al., DIFFERENTIATION INDUCTION BY A TUMOR-NECROSIS-FACTOR MUTANT-471 IN HUMAN MYELOGENOUS LEUKEMIC-CELLS VIA TUMOR-NECROSIS-FACTOR RECEPTOR-P55, International journal of cancer, 78(2), 1998, pp. 223-232
The present study examined differentiation-inducing activity by variou
s tumor-necrosis-factor(TNF) mutants against the human leukemic cell l
ines HL-60 and U-937, Mutant TNF 471, from which 7 N-terminal amino ac
ids of native TNF were deleted and pro(8), Ser(9) and Asp(10) were rep
laced by Arg, Lys and Arg, possessed the highest activity among the TN
F mutants, and its activity was 120-fold that of native TNF, The vario
us biological activities of TNF were signaled through 2 distinct recep
tors, p55 and p75, Although cytotoxicity was reported to involve mainl
y p55, this differentiation inducing activity was not well understood,
The fact that the affinity of TNF 471 was higher to p55 and lower to
p75 than that of native TNF by a binding competition assay suggested t
hat the differentiation-inducing activity was also signaled through p5
5. To verify this hypothesis, the human myelogenous leukemic cell line
, KC-1, which scarcely expresses either receptor and does not differen
tiate with TNF, was transduced with the p55 or p75 gene. Subsequently
p55 transfectants manifested a greater ability to differentiate; howev
er, p75 transfectants did not differ from parental cells or from mock-
transfectants. Further, the differentiation of p55 transfectants induc
ed by TNF was reduced by the inhibitor of protein-kinase-C (PKC), stau
rosporine. These results indicate that the differentiation-inducing ac
tivity was signaled through the TNF receptor, p55, via PKC and that th
e excellent ability of TNF 471 to induce differentiation was related t
o its high affinity for p55. (C) 1998 Wiley-Liss, Inc.